Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future Challenges
Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma...
Read More
Kidney Cancer Journal
Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice
Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice Abstract The...
Read More
Translating Metabolic Reprogramming into New Targets for Kidney Cancer
Translating Metabolic Reprogramming into New Targets for Kidney Cancer Abstract In the age...
Read MoreExercise & Wellness
Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan